Skip to Content
Merck
  • Inhibition of diacylglycerol acyltransferase by 2-bromooctanoate in cultured rat hepatocytes.

Inhibition of diacylglycerol acyltransferase by 2-bromooctanoate in cultured rat hepatocytes.

The Journal of biological chemistry (1985-06-10)
N Mayorek, J Bar-Tana
ABSTRACT

Triacylglycerol synthesis in cultured rat hepatocytes was inhibited by 2-bromooctanoate with a concomitant accumulation of diacylglycerols. 2-Bromooctanoate inhibition could be ascribed to its thioesterification by medium chain fatty acyl-CoA synthase (Raaka, B.M., and Lowenstein, J.M. (1979) J. Biol. Chem. 254, 6755-6762) with 2-bromooctanoyl-CoA acting as a competitive inhibitor of diacylglycerol acyltransferase. The Ki of 2-bromooctanoyl-CoA was 1.5 microM compared with a Km of 25 microM for the palmitoyl-CoA substrate. Diacylglycerol esterification was also inhibited by C12-C16 2-bromo fatty acids. However, inhibition of triacylglycerol synthesis by long chain 2-bromo fatty acids was accompanied by decreased overall neutral lipid synthesis as a result of inhibition of the long chain fatty acyl-CoA synthase. Since 2-bromooctanoate was a poor inhibitor of the long chain fatty acyl-CoA synthase, it appears to function selectively as an inhibitor of diacylglycerol acyltransferase in cultured rat hepatocytes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Bromooctanoic acid, 97%